189 related articles for article (PubMed ID: 12537938)
1. Novel concepts in the staging of renal cell carcinoma.
Leibovici D; Lindner A; Sella A; Zisman A
Curr Urol Rep; 2003 Feb; 4(1):41-8. PubMed ID: 12537938
[TBL] [Abstract][Full Text] [Related]
2. Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.
Martella O; Galatioto GP; Necozione S; Pomante R; Vicentini C
Arch Ital Urol Androl; 2011 Sep; 83(3):121-7. PubMed ID: 22184835
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.
Shao Y; Xiong S; Sun G; Dou W; Hu X; Yang W; Lia T; Deng S; Wei Q; Zeng H; Li X
Cancer Med; 2020 Feb; 9(3):959-970. PubMed ID: 31840431
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in renal cell carcinoma.
Volpe A; Patard JJ
World J Urol; 2010 Jun; 28(3):319-27. PubMed ID: 20364259
[TBL] [Abstract][Full Text] [Related]
5. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
6. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.
Li L; Shi L; Zhang J; Fan Y; Li Q
Cancer Med; 2021 Jan; 10(2):605-614. PubMed ID: 33280246
[TBL] [Abstract][Full Text] [Related]
7. Validation of the ucla integrated staging system for patients with renal cell carcinoma.
Zisman A; Pantuck AJ; Figlin RA; Belldegrun AS
J Clin Oncol; 2001 Sep; 19(17):3792-3. PubMed ID: 11533107
[No Abstract] [Full Text] [Related]
8. Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.
Guo S; Yao K; He X; Wu S; Ye Y; Chen J; Wu CL
Cancer Med; 2019 Sep; 8(12):5629-5637. PubMed ID: 31407495
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment.
Kattan MW
Urology; 2010 Jun; 75(6):1371; author reply 1371-2. PubMed ID: 20513496
[No Abstract] [Full Text] [Related]
10. [Prognostic parameters in renal cell carcinoma--a new approach. 1989].
Störkel S; Thoenes W; Jacobi GH; Lippold R
Aktuelle Urol; 2004 Feb; 35(1):18-21. PubMed ID: 15046020
[No Abstract] [Full Text] [Related]
11. Renal cell carcinoma--prognostic factors.
Marshall FF
J Urol; 2003 Dec; 170(6 Pt 1):2233. PubMed ID: 14634385
[No Abstract] [Full Text] [Related]
12. Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma.
Cho HJ; Kim SJ; Ha US; Hong SH; Kim JC; Choi YJ; Hwang TK
Eur Urol; 2009 Dec; 56(6):1006-12. PubMed ID: 19135776
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
14. Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.
Bailey GC; Boorjian SA; Ziegelmann MJ; Westerman ME; Lohse CM; Leibovich BC; Cheville JC; Thompson RH
BJU Int; 2017 Apr; 119(4):585-590. PubMed ID: 27696652
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
[TBL] [Abstract][Full Text] [Related]
16. High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
[No Abstract] [Full Text] [Related]
17. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.
Sandlund J; Oosterwijk E; Grankvist K; Oosterwijk-Wakka J; Ljungberg B; Rasmuson T
BJU Int; 2007 Sep; 100(3):556-60. PubMed ID: 17608827
[TBL] [Abstract][Full Text] [Related]
18. The role of nephron-sparing surgery for renal cell carcinoma.
Novick AC
Eur Urol; 1990; 18 Suppl 2():24-5. PubMed ID: 2226600
[No Abstract] [Full Text] [Related]
19. Editorial comment.
Pomara G; Francesca F
Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
[No Abstract] [Full Text] [Related]
20. [Controversies in surgical therapy of renal cell carcinoma].
Schröder A; Lampel A; Eggersmann C; Thüroff JW
Urologe A; 1997 Sep; 36(5):W460-6. PubMed ID: 9424788
[No Abstract] [Full Text] [Related]
[Next] [New Search]
